Skip to content
10-Q

Quarterly Report

10x Genomics, Inc. TXG

0001770787-24-000073

← back to feed
Filed
Oct 29, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Current Liabilities Q3 2024 · Sep 30, 2024 $121.24M
Current Liabilities Q3 2024 · Dec 31, 2023 $127.16M
Total Liabilities Q3 2024 · Sep 30, 2024 $214.99M
Total Liabilities Q3 2024 · Dec 31, 2023 $224.1M
Current Assets Q3 2024 · Sep 30, 2024 $593.89M
Current Assets Q3 2024 · Dec 31, 2023 $596.02M
Total Assets Q3 2024 · Sep 30, 2024 $937.79M
Total Assets Q3 2024 · Dec 31, 2023 $965.14M
Shares Diluted Q3 2024 · Sep 30, 2023 117.73M sh
Shares Diluted Q3 2024 · Sep 30, 2023 116.69M sh
Capex Q3 2024 · Sep 30, 2023 $45.15M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$40.96M
Stockholders Equity Q3 2024 · Sep 30, 2023 $745.22M
Stockholders Equity Q3 2024 · Jun 30, 2023 $793.3M
Stockholders Equity Q3 2024 · Mar 31, 2023 $802.39M
Stockholders Equity Q3 2024 · Dec 31, 2022 $805.74M
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.79
Eps Diluted Q3 2024 · Sep 30, 2023 −$1.77
Eps Basic Q3 2024 · Sep 30, 2023 −$0.79
Eps Basic Q3 2024 · Sep 30, 2023 −$1.77
Sga Expense Q3 2024 · Sep 30, 2023 $82.42M
Sga Expense Q3 2024 · Sep 30, 2023 $257.21M
Net Income Q3 2024 · Sep 30, 2023 −$92.99M
Net Income Q3 2024 · Sep 30, 2023 −$206.15M
Net Income Q3 2024 · Jun 30, 2023 −$62.41M
Net Income Q3 2024 · Mar 31, 2023 −$50.75M
Operating Income Q3 2024 · Sep 30, 2023 −$94.8M
Operating Income Q3 2024 · Sep 30, 2023 −$210.14M
Gross Profit Q3 2024 · Sep 30, 2023 $95.53M
Gross Profit Q3 2024 · Sep 30, 2023 $293.53M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $58.12M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $141.22M
Revenue Q3 2024 · Sep 30, 2023 $153.64M
Revenue Q3 2024 · Sep 30, 2023 $434.75M